The European Society for Translational Medicine (EUSTM) defines translational medicine (TM) as "an interdisciplinary branch of the biomedical field supported by three main pillars: bench side, bedside, and community." The purpose of TM is to improve prevention, diagnostics, and therapies by combining disciplines, resources, skills, and techniques within these pillars. As a result, translational medicine is a highly interdisciplinary subject whose main purpose is to bring together assets of various kinds within distinct pillars in order to significantly improve the global healthcare system. Clinical research and development are heavily reliant on translational medicine. It is a multidisciplinary area that brings together researchers, doctors, and patients in an endeavour to move breakthroughs from the lab to the clinic, as well as to supplement fundamental research with data from clinical trials. Translational medicine sits at the crossroads of basic research, which attempts to better understand disease causes, and clinical research, which evaluates the efficacy and safety of new treatments for patients. Translation of scientific discoveries into innovative medicines that improve patient health requires this collaborative discipline. Translational medicine brings together the expertise of academics, pharmacologists, and clinicians to evaluate new medicines and, as a result, speed up the entire drug development process. It can be used to treat any ailment.
Title : A revolution or surrender: The success and failures of tissue engineering and regenerative medicine
Thomas J Webster, Hebei University of Technology, United States
Title : Efficacy and safety outcomes in patients with chronic traumatic brain injury: Final analysis of the randomized, double-blind, surgical sham-controlled phase 2 STEMTRA trial
Bijan Nejadnik, SanBio, Inc, United States
Title : Light-based bioprinting: From bioink design to modulation of cell response in bioprinted hydrogels
Ruben F Pereira, University of Porto, Portugal
Title : Biofabrication of functional human intestinal tissue with villi and crypts using high-resolution 3D printing technique
Lindy Jang, Lawrence Livermore National Laboratory, United States
Title : Embracing the potential of biopolymer based hydrogel: The new frontier in chronic wound therapy
Madhu Gupta, School of Pharmaceutical Sciences, India
Title : A 3D -bioprinted in vitro adipose tissue model for the study of macrophage polarisation and function within metabolic disease.
Tiah Oates, University of Bristol, United Kingdom